Corton Capital’s AnaptysBio ANAB Stock Holding History

Corton Capital’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-12,004	Closed	-$266K	–	205
2025 Q2	$266K	Buy	12,004 +1,305	+12%	+$27.3K	0.31%	114
2025 Q1	$199K	Buy	+10,699	New	+$178K	0.66%	66
2024 Q4	–	Sell	-7,684	Closed	-$257K	–	386
2024 Q3	$257K	Sell	7,684 -2,840	-27%	-$97K	0.13%	253
2024 Q2	$264K	Buy	+10,524	New	+$245K	0.14%	236
2022 Q2	–	Sell	-13,614	Closed	-$337K	–	334
2022 Q1	$337K	Buy	+13,614	New	+$412K	0.15%	197

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Corton Capital's ANAB Position: Q3 2025 in Review

Corton Capital sold out of AnaptysBio (ANAB) in Q3 2025, closing a stake of 12,004 shares — an estimated $266K sold.

Corton Capital first reported a position in ANAB in Q1 2022 and held it in 5 quarters. The position peaked at $337K in Q1 2022. 166 funds tracked by Wall St. Rank hold ANAB as of Q3 2025.

Corton Capital reported no remaining AnaptysBio position as of Q3 2025 after selling out during the quarter.
Corton Capital sold 12,004 AnaptysBio shares in Q3 2025, an estimated $266K.
Corton Capital first reported a position in AnaptysBio in Q1 2022 and held it in 5 quarters.
Corton Capital's AnaptysBio position peaked at $337K in Q1 2022.
166 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2025.

Based on Corton Capital's 13F filing for Q3 2025, filed 14 Nov 2025.